Cargando…
Oral mosapride can provide additional anti-emetic efficacy following total joint arthroplasty under general anesthesia: a randomized, double-blinded clinical trial
BACKGROUND: We sought to determine (1) whether the addition of prophylactic oral mosapride to a protocol including dexamethasone and ondansetron further reduces postoperative nausea and vomiting (PONV) compared with ondansetron alone or the combination of both; (2) whether preemptive application of...
Autores principales: | Xie, Jinwei, Cai, Yingchun, Ma, Jun, Huang, Qiang, Pei, Fuxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712529/ https://www.ncbi.nlm.nih.gov/pubmed/33267769 http://dx.doi.org/10.1186/s12871-020-01214-4 |
Ejemplares similares
-
Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study
por: Lim, Hyun Chul, et al.
Publicado: (2013) -
Plasma D-dimer and FDP are promising biomarkers to predict perioperative fibrinolysis and bleeding following primary total joint arthroplasty: A STROBE compliant article
por: Wang, Yan, et al.
Publicado: (2021) -
Mosapride-Induced Movement Disorders
por: Hong, Sang-Wook, et al.
Publicado: (2022) -
A nested case-control study on the risk factors of deep vein thrombosis for Chinese after total joint arthroplasty
por: Xu, Hong, et al.
Publicado: (2019) -
Incidence and risk factors associated with human albumin administration following total joint arthroplasty: a multicenter retrospective study
por: Zhang, Shaoyun, et al.
Publicado: (2021)